Correction 2: Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: new lessons for clinical practice from the EVA study

Oncotarget. 2018 Nov 30;9(94):36720-36721. doi: 10.18632/oncotarget.26431.

Abstract

[This corrects the article DOI: 10.18632/oncotarget.25874.].

Publication types

  • Published Erratum